Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06244368Phase 2Recruiting
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Diffuse Large B-cell LymphomaPeripheral T Cell Lymphoma
PrincipalinvestigatorStart date: 2024-01-17

Research Network

Collaboration Network

18 collaborators·60 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

First Affiliated Hospital of Harbin Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Moderately Similar
12 trials

Shared therapeutic areas:

Lymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse
Similarity Score30%

Mitchell Cairo, MD

New York Medical College

Moderately Similar
14 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral
Similarity Score30%

Xiaobo Wang

The Second Affiliated Hospital of Dalian Medical University

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Wanling Sun

Xuanwu Hospital, Beijing

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

HaiSheng、Chen Liu 、Huang

Hebei Medical University Fourth Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Shuxia Guo

People's Hospital of Zhengzhou University

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Yanli Yang

The First Affiliated Hospital of Bengbu Medical University

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Xiaojing Yan

First Hospital of China Medical University

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Yunhong Huang

Affiliated Cancer Hospital & Institute of Guizhou Medical University

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Yongqian Jia

Chengdu Shangjin Nanfu Hospital

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, T-Cell, Peripheral

Worked with same sponsors:

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityBeijing Tongren Hospital+17 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06244368Phase 2PrincipalInvestigator

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Diffuse Large B-cell LymphomaPeripheral T Cell Lymphoma
Recruiting

All 1 trials loaded